Yüklüyor......
Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
Latency-reversing agents (LRAs) are considered a potential tool to cure human immunodeficiency virus type 1 (HIV-1) infection, but when they are taken alone, virus production by reactivated cells and subsequent infection will occur. Hence, it is crucial to simultaneously take appropriate measures to...
Kaydedildi:
| Yayımlandı: | Front Microbiol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156138/ https://ncbi.nlm.nih.gov/pubmed/30283406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.02022 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|